TCTMD

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?
Medscape

New TAVR Embolic Protection Device Holds Its Own in Head-to-Head Trial: PROTECT H2H

A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...
Business Wire

Protembis Announces Completion of 20 Cases in European CE Mark Study With the ProtEmbo ® Cerebral Protection System

AACHEN, Germany--(BUSINESS WIRE)--Protembis GmbH, a privately held emerging medical device company, announced today the successful completion of 20 clinical cases in its European regulatory study of ...
Business Wire

Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.

SANTA ROSA, Calif.--(BUSINESS WIRE)--Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection ...
VentureBeat

German Medtech Protembis Gets €20 Million EIB Backing for Technology to Protect Brain During Heart Treatment

The European Investment Bank (EIB) is providing €20 million in venture-debt financing to German medical-technology company Protembis to develop a next-generation device for protecting the brains of ...
Healio

Cerebral embolic protection device may lower stroke risk, severity after TAVR

Please provide your email address to receive an email when new articles are posted on . Adults who underwent transcatheter aortic valve replacement with a cerebral protection system experienced fewer ...
TCTMD

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

SENTINEL trial to evaluate the Safety and Efficacy of the Sentinel CPS in TAVR population SANTA ROSA, CA. -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during ...
VentureBeat

Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial

Only CEP Trial Designed as a Superiority Trial using DW-MRI to Demonstrate Effectiveness Against the Currently Approved Sentinel Device NEW YORK & AACHEN, Germany–(BUSINESS WIRE)–April 2, 2024– ...
Business Insider

Keystone Heart Applauds FDA Advisory Panel for Recognition of The Need for Cerebral Protection Following TAVR

CAESAREA, Israel and TAMPA, Fla., Feb. 27, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral embolic protection devices for patients ...
Nasdaq

Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System

MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection ...
Healio

Cerebral embolic protection device for TAVR safe, but not superior vs. standard care

Please provide your email address to receive an email when new articles are posted on . The device (TriGuard 3, Keystone Heart) showed potential to prevent larger ischemic brain lesions, Jeffrey W.
BioWorld

Protembis receives €20M from EIB for cerebral embolic protection system

Protembis GmbH received €20 million (US$21.66 million) in financing from the European Investment Bank to develop its cerebral embolic protection system, Protembo. The intra-aortic filter device ...